P/B
—
biote
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
$33M
Market Cap • 10/2/2026
2012
(14 years)
Founded
2022
(4 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
0,2
P/EBITDA
1,8
P/OCF
1,4
P/FCF
1,7
P/E
10,5
BVPS
—
EPS
0,2
Market Cap
Market Cap
33M
EV
158M
EV/Revenue
0,9
EV/EBITDA
8,5
EV/EBIT
10,7
Payout
Dividend Per Share
0
Dividend Yield
3,3%
Buyback Yield
27,6%
Total Yield
31%
Dividend Yield 5Y
3,3%
Payout
14,7%
Retained Earnings
-50,9M
Profitability
Gross Margin
68,6%
EBITDA Margin
10,1%
EBIT Margin
8%
Net Margin
3,9%
D&A/EBITDA
0%
R&D/Revenue
0%
Capex/Revenue
2,4%
Capex/D&A
116,9%
Capex/OCF
18,4%
SBC/OCF
34,2%
% PPE
19,4%
% Goodwill
5,7%
ROE
—
ROIC
16,1%
Leverage
N.D./EBITDA
6,3
Debt/Equity
0%
Current Ratio
1,4
Quick Ratio
0,6
Interest Coverage
157,6%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!